Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | SUPN |
---|---|---|
09:32 ET | 1128 | 34.48 |
09:34 ET | 700 | 34.47 |
09:38 ET | 1405 | 34.66 |
09:39 ET | 1024 | 34.61 |
09:41 ET | 217 | 34.82 |
09:45 ET | 500 | 34.705 |
09:48 ET | 100 | 34.7 |
09:56 ET | 100 | 34.45 |
10:03 ET | 364 | 34.355 |
10:06 ET | 200 | 34.355 |
10:08 ET | 100 | 34.355 |
10:12 ET | 300 | 34.455 |
10:14 ET | 100 | 34.455 |
10:17 ET | 590 | 34.37 |
10:26 ET | 500 | 34.11 |
10:28 ET | 100 | 34.12 |
10:30 ET | 300 | 34.19 |
10:42 ET | 900 | 34.13 |
10:44 ET | 887 | 34.015 |
10:46 ET | 2500 | 34.045 |
10:48 ET | 22695 | 34.0289 |
10:50 ET | 604 | 34.11 |
10:51 ET | 700 | 34.31 |
10:53 ET | 200 | 34.295 |
10:55 ET | 700 | 34.26 |
10:57 ET | 400 | 34.2 |
11:00 ET | 100 | 34.195 |
11:02 ET | 1100 | 34.25 |
11:04 ET | 400 | 34.255 |
11:06 ET | 1675 | 34.3 |
11:08 ET | 322 | 34.3 |
11:09 ET | 3100 | 34.45 |
11:11 ET | 100 | 34.485 |
11:15 ET | 200 | 34.52 |
11:20 ET | 100 | 34.57 |
11:24 ET | 760 | 34.58 |
11:26 ET | 200 | 34.58 |
11:29 ET | 200 | 34.58 |
11:31 ET | 200 | 34.58 |
11:33 ET | 200 | 34.58 |
11:38 ET | 300 | 34.585 |
11:40 ET | 100 | 34.65 |
11:42 ET | 100 | 34.58 |
11:44 ET | 900 | 34.695 |
11:45 ET | 100 | 34.7 |
11:47 ET | 745 | 34.775 |
11:49 ET | 100 | 34.86 |
11:51 ET | 2155 | 34.72 |
11:54 ET | 300 | 34.79 |
11:58 ET | 600 | 34.92 |
12:00 ET | 400 | 34.92 |
12:02 ET | 2682 | 34.95 |
12:03 ET | 300 | 34.95 |
12:07 ET | 377 | 34.99 |
12:09 ET | 800 | 34.86 |
12:12 ET | 200 | 34.9 |
12:16 ET | 200 | 34.865 |
12:20 ET | 300 | 34.865 |
12:21 ET | 600 | 34.925 |
12:23 ET | 300 | 34.95 |
12:30 ET | 900 | 34.9 |
12:32 ET | 100 | 34.91 |
12:36 ET | 200 | 34.88 |
12:38 ET | 200 | 34.88 |
12:39 ET | 700 | 34.8025 |
12:41 ET | 100 | 34.785 |
12:43 ET | 200 | 34.78 |
12:45 ET | 1022 | 34.74 |
12:52 ET | 100 | 34.65 |
12:56 ET | 300 | 34.615 |
12:57 ET | 100 | 34.615 |
12:59 ET | 700 | 34.59 |
01:01 ET | 300 | 34.61 |
01:03 ET | 1012 | 34.65 |
01:06 ET | 500 | 34.65 |
01:08 ET | 1123 | 34.562 |
01:10 ET | 400 | 34.5 |
01:12 ET | 2706 | 34.56 |
01:17 ET | 300 | 34.61 |
01:19 ET | 600 | 34.54 |
01:21 ET | 100 | 34.49 |
01:32 ET | 100 | 34.53 |
01:37 ET | 100 | 34.48 |
01:39 ET | 200 | 34.48 |
01:42 ET | 100 | 34.45 |
01:44 ET | 100 | 34.47 |
01:48 ET | 2800 | 34.405 |
01:50 ET | 400 | 34.44 |
01:51 ET | 800 | 34.46 |
01:57 ET | 2300 | 34.43 |
02:00 ET | 2087 | 34.46 |
02:02 ET | 200 | 34.47 |
02:04 ET | 400 | 34.46 |
02:06 ET | 300 | 34.46 |
02:08 ET | 1600 | 34.435 |
02:09 ET | 900 | 34.455 |
02:13 ET | 7840 | 34.41 |
02:15 ET | 1158 | 34.31 |
02:20 ET | 200 | 34.275 |
02:29 ET | 562 | 34.31 |
02:31 ET | 4079 | 34.21 |
02:33 ET | 200 | 34.22 |
02:38 ET | 300 | 34.16 |
02:40 ET | 100 | 34.2 |
02:42 ET | 1590 | 34.19 |
02:44 ET | 200 | 34.23 |
02:45 ET | 300 | 34.225 |
02:47 ET | 500 | 34.27 |
02:49 ET | 200 | 34.295 |
02:51 ET | 408 | 34.27 |
02:54 ET | 6587 | 34.35 |
02:56 ET | 2020 | 34.3 |
02:58 ET | 116 | 34.2835 |
03:00 ET | 300 | 34.28 |
03:02 ET | 600 | 34.32 |
03:07 ET | 801 | 34.22 |
03:09 ET | 1033 | 34.205 |
03:12 ET | 104 | 34.23 |
03:14 ET | 300 | 34.21 |
03:16 ET | 300 | 34.25 |
03:18 ET | 274 | 34.28 |
03:20 ET | 2929 | 34.21 |
03:21 ET | 22033 | 34.25 |
03:25 ET | 700 | 34.3 |
03:27 ET | 200 | 34.36 |
03:30 ET | 500 | 34.36 |
03:32 ET | 700 | 34.41 |
03:34 ET | 300 | 34.41 |
03:36 ET | 300 | 34.38 |
03:38 ET | 200 | 34.42 |
03:39 ET | 3340 | 34.3 |
03:41 ET | 2475 | 34.24 |
03:43 ET | 400 | 34.23 |
03:45 ET | 600 | 34.215 |
03:48 ET | 400 | 34.21 |
03:50 ET | 1100 | 34.225 |
03:52 ET | 1770 | 34.21 |
03:54 ET | 1414 | 34.2 |
03:56 ET | 3234 | 34.135 |
03:57 ET | 2992 | 34.095 |
03:59 ET | 71258 | 34.07 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
Supernus Pharmaceuticals Inc | 1.9B | 385.7x | -59.02% |
Phibro Animal Health Corp | 959.9M | 388.3x | -46.35% |
Eagle Pharmaceuticals Inc | 6.5M | 0.7x | -4.75% |
Shengtai Pharmaceutical Inc | 10.0 | 0.0x | --- |
Medicine Man Technologies Inc | 6.2M | --- | --- |
Elite Pharmaceuticals Inc | 464.7M | 23.2x | --- |
Supernus Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases. Its diverse neuroscience portfolio includes approved treatments for epilepsy, migraine, attention-deficit hyperactivity disorder (ADHD), hypomobility in Parkinson’s Disease (PD), cervical dystonia, chronic sialorrhea, dyskinesia in PD patients receiving levodopa-based therapy, and drug-induced extrapyramidal reactions in adult patients. The Company is also developing a range of novel CNS product candidates, including new potential treatments for hypomobility in PD, epilepsy, depression, and other CNS disorders. Its commercial products, including Qelbree (viloxazine), GOCOVRI (amantadine), Oxtellar XR (oxcarbazepine), Trokendi XR (topiramate), APOKYN (apomorphine hydrochloride injection) and others. Qelbree (viloxazine) is a novel non-stimulant product indicated for the treatment of ADHD.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $1.9B |
---|---|
Revenue (TTM) | $630.2M |
Shares Outstanding | 55.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.88 |
EPS | $0.09 |
Book Value | $16.84 |
P/E Ratio | 385.7x |
Price/Sales (TTM) | 3.0 |
Price/Cash Flow (TTM) | 21.3x |
Operating Margin | 4.21% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.